Mortality and morbidity in relation to changes in albuminuria, glucose status and systolic blood pressure: an analysis of the ONTARGET and TRANSCEND studies (Q44034435)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Mortality and morbidity in relation to changes in albuminuria, glucose status and systolic blood pressure: an analysis of the ONTARGET and TRANSCEND studies	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

29 November 2017

Mortality and morbidity in relation to changes in albuminuria, glucose status and systolic blood pressure: an analysis of the ONTARGET and TRANSCEND studies (English)

1 reference

Europe PubMed Central

29 November 2017

0 references

1 reference

based on heuristic

inferred from title

Giuseppe Mancia

5

object named as

Giuseppe Mancia

1 reference

Europe PubMed Central

29 November 2017

9

object named as

Salim Yusuf

1 reference

Europe PubMed Central

29 November 2017

Roland E. Schmieder

1

object named as

Roland E Schmieder

1 reference

Europe PubMed Central

29 November 2017

author name string

Rudolph Schutte

2

1 reference

Europe PubMed Central

29 November 2017

Helmut Schumacher

3

1 reference

Europe PubMed Central

29 November 2017

Michael Böhm

4

1 reference

Europe PubMed Central

29 November 2017

Michael A Weber

6

1 reference

Europe PubMed Central

29 November 2017

Matthew McQueen

7

1 reference

Europe PubMed Central

29 November 2017

Koon Teo

8

1 reference

Europe PubMed Central

29 November 2017

ONTARGET/TRANSCEND investigators

10

1 reference

Europe PubMed Central

29 November 2017

publication date

19 July 2014

1 reference

Europe PubMed Central

29 November 2017

1 reference

Europe PubMed Central

29 November 2017

57

1 reference

Europe PubMed Central

29 November 2017

10

1 reference

Europe PubMed Central

29 November 2017

2019-2029

1 reference

Europe PubMed Central

29 November 2017

https://scigraph.springernature.com/pub.10.1007/s00125-014-3330-9

0 references

The pathologic continuum of diabetic vascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Impact of diabetes on cardiovascular disease: an update

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Implications of proteinuria: CKD progression and cardiovascular outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Cardiovascular events and all-cause mortality by albuminuria and decreased glomerular filtration rate in patients with vascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Changes in albuminuria predict mortality and morbidity in patients with vascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Rapid progression of albumin excretion is an independent predictor of cardiovascular mortality in patients with type 2 diabetes and microalbuminuria

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Absolute level and rate of change of albuminuria over 1 year independently predict mortality and cardiovascular events in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Relation of reduction in urinary albumin excretion to ten-year cardiovascular mortality in patients with type 2 diabetes and systemic hypertension.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Telmisartan, ramipril, or both in patients at high risk for vascular events

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Effects of telmisartan on glucose levels in people at high risk for cardiovascular disease but free from diabetes: the TRANSCEND study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

A new equation to estimate glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Low-grade albuminuria and cardiovascular risk : what is the evidence?

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Epidemiology of type 2 diabetes and cardiovascular disease: translation from population to prevention: the Kelly West award lecture 2009.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Evidence for a dose effect of renin-angiotensin system inhibition on progression of microalbuminuria in Type 2 diabetes: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Albumin-to-creatinine ratio in random urine samples might replace 24-h urine collections in screening for micro- and macroalbuminuria in pregnant woman with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3330-9

21 January 2018

Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25037746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25037746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25037746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends in cardiovascular complications of diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25037746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Albuminuria as a risk factor for peripheral arterial disease in a general population: the Hisayama study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25037746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population

1 reference

https://pubmed.ncbi.nlm.nih.gov/25037746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Albuminuria is an independent predictor of all-cause and cardiovascular mortality in the Japanese population: the Takahata study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25037746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/25037746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Change in albuminuria is predictive of cardiovascular outcome in normotensive patients with type 2 diabetes and microalbuminuria

1 reference

https://pubmed.ncbi.nlm.nih.gov/25037746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25037746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glomerular filtration rate, albuminuria and risk of cardiovascular and all-cause mortality in type 2 diabetic individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/25037746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-014-3330-9

1 reference

Europe PubMed Central

29 November 2017

1 reference

Europe PubMed Central

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44034435&oldid=2105814974"